eFFECTOR Therapeutics Management
Management criteria checks 1/4
eFFECTOR Therapeutics' CEO is Steve Worland, appointed in May 2012, has a tenure of 11.83 years. total yearly compensation is $3.84M, comprised of 14.7% salary and 85.3% bonuses, including company stock and options. directly owns 0.73% of the company’s shares, worth €420.88K. The average tenure of the management team and the board of directors is 3.3 years and 2.6 years respectively.
Key information
Steve Worland
Chief executive officer
US$3.8m
Total compensation
| CEO salary percentage | 14.7% |
| CEO tenure | 11.8yrs |
| CEO ownership | 0.7% |
| Management average tenure | 3.3yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$36m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$37m |
| Mar 31 2023 | n/a | n/a | -US$36m |
| Dec 31 2022 | US$4m | US$567k | -US$23m |
| Sep 30 2022 | n/a | n/a | US$6m |
| Jun 30 2022 | n/a | n/a | US$24m |
| Mar 31 2022 | n/a | n/a | US$25m |
| Dec 31 2021 | US$3m | US$501k | US$16m |
| Sep 30 2021 | n/a | n/a | -US$4m |
| Jun 30 2021 | n/a | n/a | -US$20m |
| Mar 31 2021 | n/a | n/a | -US$7m |
| Dec 31 2020 | US$645k | US$452k | US$166k |
Compensation vs Market: Steve's total compensation ($USD3.84M) is above average for companies of similar size in the German market ($USD390.92K).
Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.
CEO
Steve Worland (65 yo)
11.8yrs
Tenure
US$3,843,052
Compensation
Dr. Stephen T. Worland, also known as Steve, Ph.D. serves as Director at Blacksmith Medicines, Inc. He has been President and Chief Executive Officer of eFFECTOR Therapeutics, Inc. since May 2012 and has b...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 11.8yrs | US$3.84m | 0.73% € 420.9k | |
| Chief Financial Officer | 3.3yrs | US$1.98m | 0.038% € 22.0k | |
| Chief Medical Officer | 1.6yrs | US$711.96k | 0% € 0 | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data |
3.3yrs
Average Tenure
51yo
Average Age
Experienced Management: LWK1's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.6yrs | US$3.84m | 0.73% € 420.9k | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.6yrs | US$80.86k | 0.032% € 18.4k | |
| Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | 0.0079% € 4.6k | |
| Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Independent Chairman | 4.2yrs | US$104.86k | 0.026% € 15.2k | |
| Independent Director | 3.2yrs | US$74.58k | 0% € 0 | |
| Member of Clinical & Scientific Advisory Board | no data | no data | no data |
2.6yrs
Average Tenure
57.5yo
Average Age
Experienced Board: LWK1's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.